Skip to main content

Contact us

X

Tell me more about STRAVIX PL Tissue and STRAVIX^◊ Cryopreserved Umbilical Tissue

Products
- Certifications
Our difference
Wound care
Surgical use
Studies
Videos
Request a demo

Contact Us

Educational resources

Placental Tissue Science & Therapeutic Applications

Educational Content, Resources, & Events

Accredited Wound Care Courses

References

Dhall S, Coksaygan T, Hoffman T, et al. Viable cryopreserved umbilical tissue (vCUT) reduces post-operative adhesions in a rabbit abdominal adhesion model. Bioact Mater. 2018; 4(1): 97-106.
Data on file at Osiris Therapeutics, Inc.
Escandon J, Vivas AC, Tang J, Rowland KJ, Kirsner RS. High mortality in patients with chronic wounds: Mortality and chronic wounds. Wound Repair Regen. 2011;19(4):526-528.
Woo KY, Support Surfaces for Skin Grafts and Flaps: A Scoping Review. Woundsource (White Paper) 2014.
Inui T, Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg. 2015; 28(3-4): 201-7.
Ahmad G, O’Flynn H, Hindocha A, et al. Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2015; (4): CD000475. 7. Krueger EA, Wilkins EG, Strawderman M, et al. Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys. 2001; 49(3): 713-21.
Giles KA, Hamdan AD, Pomposelli FB, et al. Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg. 2010; 24(1): 48-56.
Rasouli MR, Restrepo C, Maltenfort MG, et al. Risk factors for surgical site infection following total joint arthroplasty. J Bone Joint Surg Am. 2014; 96(18): e158.
Breyer BN, McAninch JW, Whitson JM, et al. Multivariate analysis of risk factors for long-term urethroplasty outcome. J Urol. 2010; 183(2): 613-7.
Sayles M, Grant DG. Preventing pharyngo-cutaneous fistula in total laryngectomy: a systematic review and meta-analysis. Laryngoscope. 2014; 124(5): 1150-63.
Korol E, Johnston K, Waser N, et al. A systematic review of risk factors associated with surgical site infections among surgical patients. PLoS One. 2013; 8(12): e83743.
Pinkney TD, Calvert M, Bartlett DC, et al. Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial). BMJ. 2013; 347: f4305.
Healy MA, Mullard AJ, Campbell DA Jr, Dimick JB. Hospital and Payer Costs Associated With Surgical Complications. JAMA Surg. 2016;151(9):823-830. doi:10.1001/jamasurg.2016.0773
McGinness K, Kurtz Phelan DH. Use of viable cryopreserved umbilical tissue for soft tissue defects in patients with gas gangrene: A case series. Wounds. 2018; 30(4): 90-95.
Fincke BG, Miller DR, Turpin R. A classification of diabetic foot infections using ICD-9-CM codes: Application to a large computerized medical database. BMC Health Serv Res. 2010; 10: 192.
Brandeisky J, Kurtz Phelan DH. Clinical outcome of Achilles tendon repair using viable intact cryopreserved umbilical tissue versus standard of care. Wounds. 2017; 29(11): E111-E114.
Sundblad KW, Tassis EK. A quality improvement pilot assessment of the safety and associated outcomes of a viable cryopreserved umbilical tissue allograft as an adjunct surgical wrap in peroneus brevis tendon repair. Medicine (Baltimore). 2018 Dec;97(51):e13662.

About
Our difference
Wound care
Surgical use
Studies
Videos
Request a demo

Use of this Web site is governed by the Terms of Use, Copyright and Disclaimer and Privacy Policy. This website is intended for caregivers in the United States only. The information provided is for informational purposes only and is not intended to be medical advice. It does not replace the professional training, experience and knowledge of the healthcare provider responsible for patient care, who must base treatment upon the unique characteristics of each patient. Every patient’s case is unique and each patient should follow his or her doctor’s specific instructions. For detailed product information, including indications for use, contraindications, effects, precautions and warnings, please consult each product’s Instructions for Use (IFU) prior to use.

◊Osiris, STRAVIX PL, STRAVIX Tissue are trademarks of Osiris Therapeutics, Inc., a wholly owned direct subsidiary of Smith+Nephew Consolidated, Inc.
All Trademarks acknowledged.

STRAVIX PL & STRAVIX Tissue Customer Care: T 888-674-9551, F 443-283-4419

Advanced Wound Management Smith+Nephew, Inc.

www.smith-nephew.com

STWE41-22546-0421